Published in
American Society of Clinical Oncology, JCO Precision Oncology, 6, 2022
DOI: 10.1200/po.21.00271
Links
Tools
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
Journal article published in 2022 by
Diana Treis 
,
Ganesh Umapathy ,
Susanne Fransson ,
Jikui Guan ,
Patricia Mendoza-García ,
Joachim T. Siaw ,
Sandra Wessman,
Lena Gordon Murkes,
Jakob J. E. Stenman,
Anna Djos ,
Lotta H. M. Elfman,
John Inge Johnsen,
Bengt Hallberg,
Ruth H. Palmer ,
Tommy Martinsson
and other authors.
,
Ganesh Umapathy ,
Susanne Fransson ,
Jikui Guan ,
Patricia Mendoza-García ,
Joachim T. Siaw ,
Sandra Wessman,
Lena Gordon Murkes,
Jakob J. E. Stenman,
Anna Djos ,
Lotta H. M. Elfman,
John Inge Johnsen,
Bengt Hallberg,
Ruth H. Palmer ,
Tommy Martinsson
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 